NDC44567-0235-25: CEFTAZIDIME FOR INJECTION.
The CEFTAZIDIME FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, administration: INTRAVENOUS AND INTRAMUSCULAR, features_provided: STERILE, primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-227-3570, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAVENOUS AND INTRAMUSCULAR |
| features_provided | STERILE |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 1.000 GRAMS OF ACTIVE INGREDIENT G |
| active_medicament_medicinal_strength | 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CEFTAZIDIME FOR INJECTION 1GM VIAL 25S |
| NSN | 6505-01-227-3570 |
| ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 GRAMS OF ACTIVE INGREDIENT G |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL |
| PHYSICAL FORM | POWDER |
| SPECIAL FEATURES | EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 1 GRAM OF CEFTAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME. STORE AT 20-25 DEG C (68-77 DEG F)(SEE USP CONTROLLED ROOM TEMPERATURE) G |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME FOR INJECTION 1GM VIAL 25S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |